Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Mullen

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|December 22, 2022
The varied spectrum of nephroblastomatosis, nephrogenic rests, and Wilms tumors: Review of current definitions and challenges of the fieldElizabeth Fialkowski, Hélène Sudour-Bonnange, Gordan M Vujanic, et al.
Radiology|November 30, 2012
Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology GroupGeetika Khanna, Arlene Naranjo, Fredric Hoffer, et al.
Journal of Pediatric Surgery|January 21, 2014
Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee studyThomas E Hamilton, Douglas Barnhart, Kenneth Gow, et al.
Brain, Behavior, and Immunity|July 6, 2010
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approachSusan K Lutgendorf, Elizabeth Mullen-Houser, Daniel Russell, et al.
JCO Precision Oncology|July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid TumorsKelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Pediatric Blood & Cancer|May 28, 2016
Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology GroupPeter F Ehrlich, Thomas E Hamilton, Kenneth Gow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Genomic and Immunologic Characterization of INI1-Deficient Pediatric CancersSuzanne J Forrest, Alyaa Al-Ibraheemi, Duong Doan, et al.
JCI Insight|August 9, 2019
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumorMichael V Ortiz, Saima Ahmed, Melissa Burns, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in OncologyFrank Balis, Daniel M Green, Clarke Anderson, et al.
Cancer Medicine|June 2, 2023
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumorsRaja Shaikh, Brent R Weil, Christopher B Weldon, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|December 22, 2022
The varied spectrum of nephroblastomatosis, nephrogenic rests, and Wilms tumors: Review of current definitions and challenges of the fieldElizabeth Fialkowski, Hélène Sudour-Bonnange, Gordan M Vujanic, et al.
Radiology|November 30, 2012
Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology GroupGeetika Khanna, Arlene Naranjo, Fredric Hoffer, et al.
Journal of Pediatric Surgery|January 21, 2014
Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee studyThomas E Hamilton, Douglas Barnhart, Kenneth Gow, et al.
Brain, Behavior, and Immunity|July 6, 2010
Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approachSusan K Lutgendorf, Elizabeth Mullen-Houser, Daniel Russell, et al.
JCO Precision Oncology|July 21, 2018
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid TumorsKelly Klega, Alma Imamovic-Tuco, Gavin Ha, et al.
Pediatric Blood & Cancer|May 28, 2016
Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology GroupPeter F Ehrlich, Thomas E Hamilton, Kenneth Gow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
Genomic and Immunologic Characterization of INI1-Deficient Pediatric CancersSuzanne J Forrest, Alyaa Al-Ibraheemi, Duong Doan, et al.
JCI Insight|August 9, 2019
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumorMichael V Ortiz, Saima Ahmed, Melissa Burns, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in OncologyFrank Balis, Daniel M Green, Clarke Anderson, et al.
Cancer Medicine|June 2, 2023
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumorsRaja Shaikh, Brent R Weil, Christopher B Weldon, et al.
Pageof 3